Evidence map›Paper›PMID 23212386›Full record

ArticleNature communications2012

Diminishing returns and tradeoffs constrain the laboratory optimization of an enzyme.

Nobuhiko Tokuriki, Colin J Jackson, Livnat Afriat-Jurnou, Kirsten T Wyganowski, Renmei Tang, Dan S Tawfik

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Nature communications, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 106 papers.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed.

  1. Epistasis: Just say no!The Journal of biological chemistry · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Structural and evolutionary constraints of organophosphate resistance in dipteran carboxylesterases.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. From duplication to fusion: Expanding Dayhoff's model of protein evolution.Protein science : a publication of the Protein Society · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Addressing epistasis in the design of protein function.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

6 authors.

Nobuhiko TokurikiMichael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z4. tokuriki@msl.ubc.ca
Colin J Jackson
Livnat Afriat-Jurnou
Kirsten T Wyganowski
Renmei Tang
Dan S Tawfik

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optimization processes, such as evolution, are constrained by diminishing returns-the closer the optimum, the smaller the benefit per mutation, and by tradeoffs-improvement of one property at the cost of others. However, the magnitude and molecular basis of these parameters, and their effect on evolutionary transitions, remain unknown. Here we pursue a complete functional transition of an enzyme with a >10(9)-fold change in the enzyme's selectivity using laboratory evolution. We observed strong diminishing returns, with the initial mutations conferring >25-fold higher improvements than later ones, and asymmetric tradeoffs whereby the gain/loss ratio of the new/old activity decreased 400-fold from the beginning of the trajectory to its end. We describe the molecular basis for these phenomena and suggest they have an important role in shaping natural proteins. These findings also suggest that the catalytic efficiency and specificity of many natural enzymes may be far from their optimum.

Indexed as

BioengineeringBiological EvolutionCarboxylic Ester HydrolasesCatalysisCatalytic DomainDirected Molecular EvolutionEnzymesHydrolysisInsecticidesKineticsMutationParaoxonPhosphoric Triester HydrolasesPseudomonasarylesteraseCarboxylic Ester HydrolasesEnzymesInsecticidesParaoxonPhosphoric Triester Hydrolases

Identifiers

PMID23212386

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.